Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gordon

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 3, 2016
Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapiesHayley Bennett, Jason Gordon, Beverley Jones, et al.
BMC Cancer|July 19, 2020
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UKRobert Hawkins, Kate Fife, Michael Hurst, et al.
Clinical Drug Investigation|September 3, 2016
Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver DiseaseThomas Ward, Jason Gordon, Beverley Jones, et al.
Pharmacoeconomics|November 24, 2023
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling StudyJason Gordon, Maria Gheorghe, Cale Harrison, et al.
International Journal of Antimicrobial Agents|May 15, 2025
Antimicrobial resistance trends, predictors, and burden in England: a retrospective study using the Clinical Practice Research Datalink from 2015 to 2021Amer Taie, Maria Gheorghe, James Amos, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 11, 2020
Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial ProgrammeJason Gordon, Thomas Danne, Lee Beresford-Hulme, et al.
European Journal of Gastroenterology & Hepatology|November 11, 2016
A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspectivePhil McEwan, Nowlan Selvapatt, Ashley Brown, et al.
Paediatric Anaesthesia|September 14, 2012
A randomized trial comparing the Ambu ® Aura-i ™ with the air-Q ™ intubating laryngeal airway as conduits for tracheal intubation in childrenNarasimhan Jagannathan, Lisa E Sohn, Amod Sawardekar, et al.
BMJ Open|August 29, 2024
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic modelWenqianzi Yang, Xuemei Zhen, Xueshan Sun, et al.
European Journal of Preventive Cardiology|May 22, 2021
Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort studySara Sekelj, Belinda Sandler, Ellie Johnston, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 3, 2016
Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapiesHayley Bennett, Jason Gordon, Beverley Jones, et al.
BMC Cancer|July 19, 2020
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UKRobert Hawkins, Kate Fife, Michael Hurst, et al.
Clinical Drug Investigation|September 3, 2016
Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver DiseaseThomas Ward, Jason Gordon, Beverley Jones, et al.
Pharmacoeconomics|November 24, 2023
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling StudyJason Gordon, Maria Gheorghe, Cale Harrison, et al.
International Journal of Antimicrobial Agents|May 15, 2025
Antimicrobial resistance trends, predictors, and burden in England: a retrospective study using the Clinical Practice Research Datalink from 2015 to 2021Amer Taie, Maria Gheorghe, James Amos, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 11, 2020
Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial ProgrammeJason Gordon, Thomas Danne, Lee Beresford-Hulme, et al.
European Journal of Gastroenterology & Hepatology|November 11, 2016
A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspectivePhil McEwan, Nowlan Selvapatt, Ashley Brown, et al.
Paediatric Anaesthesia|September 14, 2012
A randomized trial comparing the Ambu ® Aura-i ™ with the air-Q ™ intubating laryngeal airway as conduits for tracheal intubation in childrenNarasimhan Jagannathan, Lisa E Sohn, Amod Sawardekar, et al.
BMJ Open|August 29, 2024
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic modelWenqianzi Yang, Xuemei Zhen, Xueshan Sun, et al.
European Journal of Preventive Cardiology|May 22, 2021
Detecting undiagnosed atrial fibrillation in UK primary care: Validation of a machine learning prediction algorithm in a retrospective cohort studySara Sekelj, Belinda Sandler, Ellie Johnston, et al.
Pageof 7